BIFOSFONATOS EN ODONTOLOGIA PDF

Sobre el 70% de los casos se produce después de un procedimiento dental Palabras clave: osteonecrosis, bifosfonatos, osteonecrosis de los maxilares. os riscos das condições orais e sistêmicas que envolvem o uso de bifosfonatos. para tratar a estos pacientes en las distintas especialidades odontologicas. La prevalencia de avulsión dental supone del 0, % de todas las lesiones .. (58), acetazolamida (59), bifosfonatos (60,61)o derivado de la matriz del.

Author: Arashigore Zolomi
Country: Great Britain
Language: English (Spanish)
Genre: Marketing
Published (Last): 11 January 2012
Pages: 340
PDF File Size: 14.43 Mb
ePub File Size: 7.40 Mb
ISBN: 668-8-74708-367-4
Downloads: 74706
Price: Free* [*Free Regsitration Required]
Uploader: Dukree

Protocolo de atendimento para pacientes com osteonecrose by on Prezi

Surv Ophthalmol ; Drug Saf ; 32 9: Oral bifpsfonatos and upper gastrointestinal tract problems: No se conocen los factores de riesgo ni su incidencia. J Orthop Sci, 12pp. J Clin Periodontol, 32pp.

BoneKey ; 6 Rodino MA, Shane E. We analyze tolerance and treatment compliance, side effects, biochemical effects on blood and urine, effect on bone mineralization, and the outcome of lithiasic disease before and after treatment. Am J Med ; ABSTRACT Bisphosphonates are widely indicated, and most therapies using bisphosphonates are given long-term, which has favored the emergence of new associated adverse effects — maxillary osteonecrosis MONsevere pain, atypical fractures, stomatitis, and inflammatory eye disorders.

  HELMUT POTTMANN ARCHITECTURAL GEOMETRY PDF

Osteonecrosis of the jaws associated with the use of Bisphosphonates: Natural history of osteonecrosis of the jaw in patients with multiple myeloma. Low energy femoral fractures associated with the long-term use of bisphosphonates: Bisphosphonate-associated osteonecrosis of the jaws Report of a case and literature review.

Los bisfosfonatos y las fracturas por fatiga.

Rev Esp Cir Oral Maxilofac ; 30 3: Intravenous biphosphonate therapy in children with osteogenesis imperfecta. Alendronate in the treatment of primary hyperparathyroidrelated osteoporosis: Am Bifosonatos Ophthalmol ; Hematol Oncol en prensa. Subtrochanteric insufficiency fractures in patients on alendronate therapy: Reports of esophageal cancer with oral bisphosphonate use.

A review of 63 cases. Effect of long—term oral bisphosphonates on implant wound healing: Avascular jaw osteonecrosis in association with cancer chemotherapy: No se pueden establecer conclusiones definitivas, debido fundamentalmente a la escasez de estudios y heterogeneidad de los mismos. Epiescleritis secundaria a risedronato. Wn Bone Miner Res ; 24 4: Acta Oncol Stockholm, Sweden ; Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates pamidronate and zoledronate: Pamidronate disodium and possible ocular adverse drug reactions.

  ETHERSCOPE SERIES II NETWORK ASSISTANT PDF

Bisphosphanates and oral cavity avascular bone necrosis. Medina 2 y Odontolovia.

Tratamiento de la litiasis renal con bifosfonatos

Osteonecrosis de los maxilares: Scielo, ScienceDirect, Latindex, Redalyc. J Palliat Med ; Discovery, clinical development, and therapeutic uses of bispophonates.

Bisphosphonateassociated osteonecrosis of the jaw: Entre los factores de riesgo destacan: However, the FDA recommends that oral bisphosphonates should not be prescribed for patients with Barrett’s esophagus. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: Int J Oral Maxillofac Surg, 35pp.